Amy Selly, CNP, AOCNP, of Allina Health Systems, discusses the evolving definition of cancer survivorship, along with important topics for clinicians to be aware of when considering their patients' survivorship journeys.
Speaking Out
Howard Edington, MD, and Patrick Wagner, MD, of Allegheny Health Network, discuss the cutting-edge field of personalized medicine, particularly viral therapy, for treatment of cancer.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
BRUIN Final Analysis: Pirtobrutinib Durable in Post-Covalent BTK CLL/SLL
2
HMA/Venetoclax Is Superior to Intensive Chemo in Fit Patients With AML
3
Chemo-Free Ponatinib/Blinatumomab Improves Survival in Ph+ ALL
4
Pirtobrutinib Shows Noninferior ORR, Trend Toward PFS Benefit Vs Ibrutinib in CLL
5
